recombinetics news
Rocco Morelli Named Interim Ceo Of Recombinetics™, Global Leader In Genetically Engineered Animals
Mark Platt assumes role as full-time President and CEO of [...]
Makana Statement about Transplant of Gal-Knockout Pig Kidney into a Recently Deceased Human with an Intact Circulation
MIAMI (October 25, 2021) – We at Makana Therapeutics and [...]
Makana Therapeutics – 2021 KidneyX “Artificial Kidney Prize – Phase 1” Winner
A winning solution to KidneyX’s inaugural prize competition, the Artificial [...]
Makana Therapeutics Awarded KidneyX Artificial Kidney Prize for Innovation in Xenotransplantation
EAGAN, Minn., Sept. 15, 2021 /PRNewswire/ -- Makana Therapeutics today [...]
First GM pigs for allergies. Could xenotransplants be next?
The FDA greenlights α-Gal allergy-safe meat, but its makers have [...]
Recombinetics Announces Study to Improve Outcomes for Rare Disease Patients
Recombinetics Inc., a leading gene editing company with platform technology [...]
Harnessing the Power of the Pig in Pursuit of Cancer Therapies
Surrogen’s Vice President of Research & Development, Dr. Adrienne Watson, [...]
Acceligen Opens Doors in Brazil
EAGAN, Minn., Oct. 14, 2020 /PRNewswire/ -- Acceligen, the leading [...]
Precision Crossbreeding of African Dairy Production Systems
EAGAN, Minn., Sept. 24, 2020 /PRNewswire/ -- Acceligen, a Recombinetics [...]
SDPB Radio: CEO of Acceligen Talks New Grant
A grant made possible by the Bill and Melinda Gates [...]